1. Biomarkers in renal-cell carcinoma: building on clinical paradigms. Issue 12 (December 2018) Authors: Agarwal, Neeraj; Nussenzveig, Roberto; Pal, Sumanta K Journal: Lancet oncology Issue: Volume 19:Issue 12(2018) Page Start: 1560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. (2020) Authors: Moses, Marcus; Niu, Alex; Lilly, Michael B.; Hahn, Andrew W.; Nussenzveig, Roberto; Ledet, Elisa; Manogue, Charlotte; Cotogno, Patrick; Lewis, Brian; Layton, Jodi; Agarwal, Neeraj; Sartor, Oliver; Barata, Pedro C. Journal: Cancer treatment and research communications Issue: Number 24(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA. Issue 2 (11th August 2020) Authors: Barata, Pedro; Agarwal, Neeraj; Nussenzveig, Roberto; Gerendash, Benjamin; Jaeger, Ellen; Hatton, Whitley; Ledet, Elisa; Lewis, Brian; Layton, Jodi; Babiker, Hani; Bryce, Alan; Garje, Rohan; Stein, Cy; Kiedrowski, Lesli; Saylor, Philip; Sartor, Oliver Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time. (2019) Authors: Hahn, Andrew W.; Stenehjem, David; Nussenzveig, Roberto; Carroll, Emma; Bailey, Erin; Batten, Julia; Maughan, Benjamin L.; Agarwal, Neeraj Journal: Cancer treatment and research communications Issue: Number 19(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial. (1st November 2018) Authors: Maughan, Benjamin L.; Pal, Sumanta K.; Gill, David; Boucher, Kenneth; Martin, Christopher; Salgia, Meghan; Nussenzveig, Roberto; Liu, Ting; Hawks, Josiah L.; Batten, Julia; Nachaegari, Gayatri; Stephenson, Robert; Lowrance, William; Jones, Jeremy; Dechet, Christopher; Agarwal, Neeraj Journal: Oncologist Issue: Volume 23:Number 12(2018) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer. (24th February 2022) Authors: Freeman, Meredith N; Jang, Albert; Zhu, Jason; Sanati, Farhad; Nandagopal, Lakshminarayanan; Ravindranathan, Deepak; Desai, Arpita; Phone, Audrey; Nussenzveig, Roberto; Jaeger, Ellen; Caputo, Sydney A; Koshkin, Vadim S; Swami, Umang; Basu, Arnab; Bilen, Mehmet A; Agarwal, Neeraj; Sartor, Oliver; ... Journal: Oncologist Issue: Volume 27:Number 3(2022) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Radium-223 Plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. (23rd September 2021) Authors: Maughan, Benjamin L.; Kessel, Adam; McFarland, Taylor Ryan; Sayegh, Nicolas; Nussenzveig, Roberto; Hahn, Andrew W.; Hoffman, John M.; Morton, Kathyrn; Sirohi, Deepika; Kohli, Manish; Swami, Umang; Boucher, Kenneth; Haaland, Benjamin; Agarwal, Neeraj Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: 1006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Radium‐223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration‐Refractory Prostate Cancer: Final Safety and Efficacy Results. (23rd September 2021) Authors: Maughan, Benjamin L.; Kessel, Adam; McFarland, Taylor Ryan; Sayegh, Nicolas; Nussenzveig, Roberto; Hahn, Andrew W.; Hoffman, John M.; Morton, Kathyrn; Sirohi, Deepika; Kohli, Manish; Swami, Umang; Boucher, Kenneth; Haaland, Benjamin; Agarwal, Neeraj Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: 1006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer. (3rd December 2020) Authors: Sena, Laura A.; Fountain, Julia; Isaacsson Velho, Pedro; Lim, Su Jin; Wang, Hao; Nizialek, Emily; Rathi, Nityam; Nussenzveig, Roberto; Maughan, Benjamin L.; Velez, Miguel Gonzalez; Ashkar, Ryan; Larson, Amanda C.; Pritchard, Colin C.; Adra, Nabil; Bryce, Alan H.; Agarwal, Neeraj; Pardoll, Drew M.... Journal: Oncologist Issue: Volume 26:Number 2(2021) Page Start: e270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗